Mechanistically, insulin resistance (IR) results in hyperinsulinemia as well as the activation of the insulin receptor and insulin-like growth factor 1 (IGF-1) signaling pathways, which are important initiators and supporters of hepatocarcinogenesis. The gene discussed is IGF1; the disease is hyperinsulinism.